3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Active not recruiting
2
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Multiple Myeloma
43
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Recurrence
7
Lymphoma, Non-Hodgkin
6
Burkitt Lymphoma
6
Neoplasms, Plasma Cell
5
Nausea
5
Leukemia
5
Vomiting
4
Prostatic Neoplasms
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Lymphoma
4
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Hematologic Neoplasms
3
Amyloidosis
3
Smoldering Multiple Myeloma
2
Oligodendroglioma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Immunoglobulin Light-chain Amyloidosis
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Astrocytoma
2
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Interventions
Rituximab
24
Cyclophosphamide
14
fludarabine
8
Etoposide
6
Vincristine
5
Prednisone
5
Doxorubicin
5
fludarabine phosphate
4
Carboplatin
4
venetoclax
3
obinutuzumab
3
ibrutinib
3
atezolizumab
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Lenalidomide
3
Ifosfamide
3
Cytarabine
3
Carmustine
3
Bortezomib
3
Bendamustine Hydrochloride
3
ublituximab
2
pembrolizumab
2
pegfilgrastim
2
ibritumomab tiuxetan
2
Tiragolumab
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Indium
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Lymphoma, B-Cell
×
Calcium Dobesilate
×
Clear all
NCT00413959
2018-09-19
VRCD
Oncology Specialists, S.C.
Phase 2
Terminated
12 enrolled
7 charts